Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance

Haematologica

Volumn 87, Issue 1, 2002, Pages 44-51

  Cuneo, Antonio ^a   Bigoni, Renato ^a   Rigolin, Gian Mateo ^a   Roberti, Maria Grazia ^a   Bardi, Antonella ^a   Cavazzini, Francesco ^a   Milani, Raffaella ^a   Minotto, Claudia ^a   Tieghi, Alessia ^a   Porta, Matteo Della ^a   Agostini, Paola ^a   Tammiso, Elisa ^a   Negrini, Massimo ^a   Castoldi, Gianluigi ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

11q deletion; ATM locus; Chronic lymphocytic leukemia

Indexed keywords

ATM PROTEIN; BETA 2 MICROGLOBULIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; SPLENOMEGALY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL CYCLE PROTEINS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KARYOTYPING; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, PROLYMPHOCYTIC; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PROTEIN-SERINE-THREONINE KINASES; SPLENOMEGALY; TUMOR SUPPRESSOR PROTEINS;

EID: 0036154582     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia
2. Karyotypic evolution in CLL: Identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease
3. Cytogenetics and molecular genetics of chronic lymphocytic leukemia
4. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival
5. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
6. Chromosome 11q rearrangements in B non Hodgkin's lymphoma
7. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
8. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants
9. Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features
10. ATM mutations in B-cell chronic lymphocytic leukemia
11. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
12. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
13. Chronic lymphocytic leukemia. Current strategy and new perspectives of treatment
14. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
15. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias
16. Atypical chronic lymphocytic leukaemia with t(11; 14)(q13; q32): Karyotype evolution and prolymphocytic transformation
17. Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11; 14)(q13; q32): Role for a p53 exon 7 gene mutation
18. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation
19. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization
20. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL
21. World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House
22. Different entities and diagnostic problems
23. The chronic lymphocytic leukemias
24. Genomic aberrations and survival in chronic lymphocytic leukemia
25. The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia. IV. Analysis of survival and prognostic features
26. Karyotypic evolution in B-cell chronic lymphocytic leukemia
27. Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia
28. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)
29. Blastic/blastoid transformation of follicular lymphoma: Immunohistologic and molecular analyzes of five cases
30. Deletions and loss of expression of p161NK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas
31. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma
32. p53 mutations are associated with histologic transformation of follicular lymphoma
33. Gain of chromosome 7, which marks the progression from indolent to aggressive follicle centre lymphomas, is restricted to the B-lymphoid cell lineage: A study by FISH in combination with morphology and immunocytochemistry
34. Secondary chromosome changes in mantle cell lymphoma
35. Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: Frequent occurrence of dicentric rearrangements and possible association with adverse outcome